Pharma Litigation Attorneys Pen Article for Law360
Taft Chicago Pharmaceutical and Life Sciences Litigation attorneys Stephen Auten and Jaimin Shah along with Sinchan Shah of Amneal Pharmaceuticals Pvt. Ltd. published “For Now, Competitive Generic Therapy Exclusivity is a Mirage” for Law360. The article discusses issues with competitive generic therapy exclusivity enacted in the Food and Drug Reauthorization Act of 2017.
In This Article
You May Also Like
Three Taft IP Attorneys Named to WTR Global Leaders 2025 Taft IP Practice and Attorneys Named to 2025 IP Stars by Managing Intellectual Property Magazine